LORBRIQUA 25MG TABLET (30S)

Introduction:

Lorbriqua 25mg Tablet is used to treat adults with unresectable (unremovable), advanced, or recurrent forms of non-small cell lung cancer (NSCLC). It works by inhibiting an enzyme called anaplastic lymphoma kinase (ALK) and is given to patients who have an alteration in this enzyme.

Furthermore, Lorbriqua 25mg Tablet is prescribed only to those patients who no longer respond to other ALK inhibitors, such as alectinib or ceritinib. Additionally, it is also effective in treating ALK-positive NSCLC that has spread to the brain.

Take this medicine with or without food, but preferably at the same time each day. Depending on the condition and response to the treatment, the doctor may alter the dose or stop the treatment for a short time. Continue taking this medicine for as long as the doctor has prescribed, and do not stop suddenly.

Instructions:

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lorbriqua 25mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Side Effects:

• Fatigue
• Diarrhea
• Edema (swelling)
• High blood pressure
• Cough
• Joint pain
• Peripheral neuropathy (tingling and numbness of feet and hand)
• Weight gain
• Breathlessness
• Mood changes
• Hypercholesterolemia (high cholesterol)
• Increased triglyceride level in blood